Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.880
+0.340 (9.60%)
At close: Mar 9, 2026, 4:00 PM EDT
3.840
-0.040 (-1.03%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of Immunotherapies and Vaccines | 41.00K | 20.00K | 426.00K | -68.00K | 4.41M | | | | | |
Research and Development of Immunotherapies and Vaccines Growth | 105.00% | -95.31% | - | - | -46.12% | | | | | |
| 41.00K | 20.00K | 426.00K | -68.00K | 4.41M | | | | | |
| 105.00% | -95.31% | - | - | -46.12% | | | | | |
Source: S&P Global Market Intelligence.
